In the BioHarmony Drug Report Database

"Preview" Icon

Prasugrel

Effient, Efient (prasugrel) is a small molecule pharmaceutical. Prasugrel was first approved as Effient on 2009-02-24. It has been approved in Europe to treat acute coronary syndrome, myocardial infarction, and unstable angina.

 

Trade Name

 

Efient
 

Common Name

 

prasugrel
 

ChEMBL ID

 

CHEMBL1201772
 

Indication

 

acute coronary syndrome, myocardial infarction, unstable angina
 

Drug Class

 

Platelet aggregation inhibitors

Image (chem structure or protein)

Prasugrel structure rendering